During the past decade, Mercy Medical Center - Des Moines conducted 203 clinical trials. In the 10-year time frame, 203 clinical trials started and 151 clinical trials were completed, i.e. on average, 74.4% percent of trials that started reached the finish line to date. In the past 5 years, 90 clinical trials started and 83 clinical trials were completed. i.e. 92.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Medical Center - Des Moines" #1 sponsor was "National Cancer Institute (NCI)" with 176 trials, followed by "SWOG Cancer Research Network" with 39 trials sponsored, "Alliance for Clinical Trials in Oncology" with 36 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 21 trials sponsored and "Gynecologic Oncology Group" with 21 trials sponsored. Other sponsors include 64 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Medical Center - Des Moines" #1 collaborator was "National Cancer Institute (NCI)" with 150 trials as a collaborator, "NRG Oncology" with 50 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator and "SWOG Cancer Research Network" with 9 trials as a collaborator. Other collaborators include 60 different institutions and companies that were collaborators in the rest 47 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Medical Center - Des Moines" are "Recurrent Ovarian Carcinoma" (20 trials), "Recurrent Fallopian Tube Carcinoma" (16 trials), "Recurrent Primary Peritoneal Carcinoma" (15 trials), "Recurrent Breast Carcinoma" (12 trials) and "Fallopian Tube Transitional Cell Carcinoma" (11 trials). Many other conditions were trialed in "Mercy Medical Center - Des Moines" in a lesser frequency.

Most popular intervention types in "Mercy Medical Center - Des Moines" are "Drug" (273 trials), "Other" (205 trials), "Biological" (135 trials), "Procedure" (82 trials) and "Radiation" (58 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (109 trials), "Quality-of-Life Assessment" (87 trials), "Questionnaire Administration" (55 trials), "Paclitaxel" (49 trials) and "Carboplatin" (42 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Medical Center - Des Moines" are 263 trials for "All" genders, 82 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "Mercy Medical Center - Des Moines". undefined are not yet recruiting, 85 are recruiting, 138 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 99 completed trials in Mercy Medical Center - Des Moines, 5 suspended trials, and 24 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Medical Center - Des Moines, 11 "Phase 1" clinical trials were conducted, 164 "Phase 2" clinical trials and 169 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 21 trials that are defined as “Not Applicable".